Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy
- PMID: 2481447
- PMCID: PMC1133617
- DOI: 10.1042/bj2640573
Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy
Abstract
1. A single subcutaneous injection of clenbuterol hydrochloride (0.125 mg/kg body wt.) to female Wistar rats produced a rapid increase in muscle cyclic AMP and lactate concentrations and a decrease in muscle glycogen concentrations. These changes are characteristic of muscle beta-adrenoceptor stimulation and were abolished by intraperitoneal injection of propranolol (12.5 mg/kg) 15 min before clenbuterol administration. 2. When this dose of clenbuterol was injected twice daily, the changes in muscle metabolite concentrations which followed its acute administration persisted until day 7 of treatment, and were accompanied by increases in muscle mass, body weight and muscle protein synthesis rate (ks). When the clenbuterol injections were preceded by propranolol injections (12.5 mg/kg administered according to the protocol described above), or if animals were treated with propranolol only, the values of these variables were not significantly different from those of sham-injected controls. 3. In rats fed on a semi-synthetic diet (PW3) supplemented with 2 mg of clenbuterol/kg of diet for 7 days, the muscle mass was greater than that of rats fed on unsupplemented PW3. The increased muscle mass was accompanied by increased muscle lactate and decreased muscle glycogen concentrations. When PW3 was supplemented with 2 mg of clenbuterol/kg and 200 mg of propranolol/kg, the increase in muscle mass remained, but decreased muscle glycogen concentrations and increased muscle lactate concentrations were also observed. 4. These data are consistent with the hypothesis that clenbuterol influences muscle growth via beta-adrenoceptor stimulation.
Similar articles
-
Propranolol apparently separates the physical and compositional characteristics of muscle growth induced by clenbuterol.Biosci Rep. 1987 Jan;7(1):51-7. doi: 10.1007/BF01122727. Biosci Rep. 1987. PMID: 2441771
-
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.Am J Physiol. 1992 Jul;263(1 Pt 1):E50-6. doi: 10.1152/ajpendo.1992.263.1.E50. Am J Physiol. 1992. PMID: 1322047
-
Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol-sensitive.Br J Pharmacol. 1989 Apr;96(4):817-22. doi: 10.1111/j.1476-5381.1989.tb11889.x. Br J Pharmacol. 1989. PMID: 2472845 Free PMC article.
-
[Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].Arch Tierernahr. 1993;45(3):211-25. doi: 10.1080/17450399309386101. Arch Tierernahr. 1993. PMID: 8585791 German.
-
Beta-adrenergic agonists and hypertrophy of skeletal muscles.Life Sci. 1992;50(6):397-407. doi: 10.1016/0024-3205(92)90374-x. Life Sci. 1992. PMID: 1346465 Review.
Cited by
-
Clenbuterol: a medal in tablet form?Br J Sports Med. 1993 Jun;27(2):141. doi: 10.1136/bjsm.27.2.141. Br J Sports Med. 1993. PMID: 8358587 Free PMC article. No abstract available.
-
Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.J Muscle Res Cell Motil. 2003;24(7):471-6. doi: 10.1023/a:1027377731137. J Muscle Res Cell Motil. 2003. PMID: 14677650
-
Salbutamol exhibits androgenic activity in vitro.Br J Sports Med. 2007 Dec;41(12):874-8; discussion 878. doi: 10.1136/bjsm.2007.035162. Epub 2007 May 17. Br J Sports Med. 2007. PMID: 17510230 Free PMC article.
-
Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.Endocrinol Diabetes Metab Case Rep. 2021 Oct 1;2021:21-0060. doi: 10.1530/EDM-21-0060. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2021. PMID: 34612209 Free PMC article.
-
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.Mol Genet Metab. 2011 Jun;103(2):107-12. doi: 10.1016/j.ymgme.2011.02.006. Epub 2011 Feb 13. Mol Genet Metab. 2011. PMID: 21397538 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources